Brazil‘s health regulator Anvisa has allowed the resumption of late-stage clinical trials for China’s Sinovac COVID-19 vaccine, which had been suspended due to the death of a volunteer that was registered in Sao Paulo as a suicide.Brazilian medical institute Butantan said in a statement it would restart trials later on Wednesday.Brazil’s President Jair Bolsonaro, a longtime China skeptic who has baselessly dismissed the Sinovac vaccine as lacking in credibility, had hailed Monday’s suspension as a personal victory.
Bolsonaro claims ‘victory’ as Chinese coronavirus vaccine trial halted in Brazil The decision was severely criticized by the trial organizers, who said the move had taken them by surprise and that there had been no need to stop.